Shanghai Tofflon Science and Technology Co., Ltd.

Thirteen years of qualification Audited Supplier

Thirteen years of qualification Audited Supplier

Company Profile
  • Year Established: 1993
  • Total Assets(USD): More than 99,999,999
  • Total Number of Staff: more than 1000
  • Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Business Type: Manufacturer
  • R&D Capacity: Own Brand
  • Annual Turnover(USD) : 500,000 to 99,999,999
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Shanghai Tofflon Science and Technology Co. Ltd. (Short for “Tofflon”, Stock Code: SZ 300171) was founded in 1993. It is a comprehensive pharmaceutical equipment supplier to provide process support, core equipments, integrated system and pharma engineering for the pharma and biotech industry in the world. Since its foundation, Tofflon has supplied more than 8000 equipments and systems for 2000 pharmaceutical companies across over 40 countries and regions in the world which have been widely applied in the fields of liquid and lyo injectables, chemical API, bio engineering and pharma packaging, etc. Today Tofflon focuses on studying drug manufacture science and process equipment manufacture science, practices drug process knowledge integration with pharma equipment knowledge. Taking “Synergy Global Advanced Technologies” strategy, Tofflon builds comprehensive development institute in Shanghai headquarters, is building design houses and technical centers in USA, Europe and India, establishes joint ventures and technology collaboration with the technical partners from USA, Europe and Japan. Furthermore Tofflon has built five modern pharmaceutical equipments manufacturing bases with global competitiveness. It has been approved with all the international regulatory certifications like German TUV ISO9001, ISO14001, OHSAS 18001, CE, UL, PED, ASME, etc. Thanks to 2000 Chinese and foreign employees professional works, it can provide competitive pharmaceutical equipment and system solutions valuable for today and future’s competence improvement of the pharma and biotech companies. In the future to commit to its mission “Expertise in Pharmaceutical Industry”, Tofflon will continuously work with pharmaceutical industry to face and meet the challenges and pressures in the industry through developing “innovative drug manufacturing science” and building “advanced drug manufacturing platform”. In the following years, Tofflon will dedicate itself to grow from “China Tofflon to Global Tofflon”, from “Equipment Supplier to Solution Provider” so as to grow up to a total solution provider of pharmaceutical manufacturing systems and engineering for the global pharma and biotech industry to contribute to the maximum benefits and welfare of its served society, customers, stockholders, employees and their families.  

Year Established: 1993

Total Assets(USD): More than 99,999,999

Total Number of Staff: more than 1000

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Business Type: Manufacturer

R&D Capacity: Own Brand

Annual Turnover(USD) : 500,000 to 99,999,999

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Top Products
Copyright 2006-2020 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by